PROX™ Antiviral Fabric is tested effective against >99% SARS-CoV-2 (Covid-19) including both Delta & Omicron variants even after 60 washes by testing conducted at Microbe Investigations AG (MIS) in Switzerland

16th August 2021     |     See the Article

Introducing ProXmask(TM): Antiviral Face Mask as Better Alternative to Double-Masking and Capable of Inactivate SARS-CoV-2

KUALA LUMPUR, Malaysia, Aug. 16, 2021 /PRNewswire/ -- ProXmask™ is the first antiviral face mask mass-produced in the Asia Pacific by Prolexus Group. The antiviral face mask created by Prolexus Group is a remarkable example of conventional OEM (original equipment manufacturer) for globally renowned sports apparel to expand the business horizon amid last year'sCOVID-19 pandemic to swiftly tap into the face mask market with highly innovative fabric technologies ahead of conventional reusable face masks in the market.

Better Filtration and Breathability compared with Double-Masking

The U.S. CDC conducted experiments highlighting the importance of good fit to maximise mask performance and effectively control the spread of COVID-19. ProXmask™ is positioned as a virus protection essential by being embedded with a high quality filtration structure and designed to fit closely against the face for a better seal and ease of breathing.

Innovative Features

ProXmask™ is also greater in terms of ease of wear and functionalities:

Dr. Zetty, Research and Development Specialist of Prolexus Group said, "We are proud to introduce ProXmask™ that will help people feel protected and alleviate the fear of COVID-19 infection while still practising hygiene and social distancing, especially at a time when a highly contagious SARS-CoV-2 virus strain is spreading."

 The innovative and cutting-edge antiviral technology is supported by a well-known European textile chemical manufacturer, HeiQ Materials AG, whereby the fundamental of the antiviral technology involves the presence of active positive charges on the fabric, as binding sites for viruses. Upon contact with the fabric, virus cells that are negatively charged are neutralised, leading to the rapid destruction of their glycoprotein layers and the release of non-infectious ribonucleic acid (RNA).

ProXmask™ is registered with FDA and CE and is also the first fabric mask in Malaysia to obtain product certification from SIRIM QAS International recognising for its product quality control. The face mask is also accredited by internationally renowned labs from Interlek, TÜV SÜD, NIOSH, and more.

Visit or email to for more information

About Prolexus Group

Founded in 1976, Prolexus Group is a public listed group of companies specializes in textile and apparel manufacturing for global brands. Aside from the Group's vertically integrated manufacturing and innovation capabilities, Prolexus has expanded its design capability by offering a one-stop solution to its customers.

SOURCE Prolexus Berhad